Ticker
ACR
Analysis
Acrux Limited (ACR) Stock Analysis
Acrux Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to ACR.
Acrux Limited
Acrux Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to ACR.
Stock profile
Asset type
Stock
Market cap
$5.5M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Currency
AUD
Ticker listings
Acrux Limited may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- ACR primary listing
- ARUXF
- FJY
Latest Acrux Limited news
Update - Licensing Lenzetto for Australia for AUD5.4m
Update - Licensing Lenzetto for Australia for AUD5.4m
Acrux licenses Lenzetto for Australian market for AUD5.4m
Acrux licenses Lenzetto for Australian market for AUD5.4m
Capital Gains Tax exemptions remain in place for Acrux
Capital Gains Tax exemptions remain in place for Acrux
Acrux raises $1.6 million via Share Placement
Acrux raises $1.6 million via Share Placement
Australian company unlocks a new era for women's health globally with an innovative delivery system for Female testosterone in women with...
Acrux is a successful Australian pharmaceutical company that develops innovative drugs for the global market. It recently announced its new strategy to enter the final, phase II...
Research sections
Valuation
Review valuation context for Acrux Limited.
Future growth
Review future growth context for Acrux Limited.
Past performance
Review past performance context for Acrux Limited.
Financial health
Review financial health context for Acrux Limited.
Dividend
Review dividend context for Acrux Limited.
Management
Review management context for Acrux Limited.
Ownership
Review ownership context for Acrux Limited.
Other information
Review other information context for Acrux Limited.
Community
Review community context for Acrux Limited.